What is TNON's dilution risk score?

TNON has a latest available DilutionScore record of 93/100, categorized as critical dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for TNON, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for TNON?

DilutionWatch tracks 25 SEC filing types for TNON including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect TNON shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For TNON, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for TNON tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for TNON. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

TNON Dilution Risk Score: 93/100 (component-limited)

Score Breakdown

📋 Offering Ability

100

💰 Cash Runway

95

📊Float Risk—

⚠️ Warrant Exposure

90

🔄 Convertible Debt

60

Dilution Forecast

⛈️

Warning

High probability of dilution event

model est. 70%

💰 Capital Raise model 75%

• Critical: only 2.3 months cash remaining

• Active shelf registration ($100M, 1252% of market cap)

🔄 Reverse Split model est. 70%

• 50-day avg $0.75 below $1 exchange minimum

• Only 2 months cash — financial pressure

📜 Warrant Exercise model 60%

• Massive warrant overhang: 37% of shares outstanding

• Warrant risk score very high (90/100)

🔔 Track TNON — Get forecast alerts →

Market Data

Market Cap$7.99M

Shares Outstanding667.0K

FloatN/A

Cash$2.17M

Debt$4.88M

Short InterestN/A

Institutional Holdings

2.1% institutional ownership

Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers

🔔 Track TNON for full holder detail →

Short Interest

Short Interest223.4K

Days to Cover1.0

% of FloatN/A

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-30

xbrl XBRL CONVERTIBLE 2023-12-31

EFFECT EFFECT 2026-08-18

S-3/A SHELF 2026-08-17

SC 13G BENEFICIAL OWNERSHIP 2026-08-14

Full SEC filing analysis available with free account →

Recent News

WallachBeth Capital Announces Tenon Medical Pricing of $3M Private Placement Off PR Newswire · Aug 28

Tenon Medical Announces Pricing of $3M Private Placement Offering ACCESS Newswire · Aug 28

Tenon Medical Regains Nasdaq Compliance MT Newswires · Aug 24

Factual TNON Dilution Snapshot

Tenon Medical, Inc. (TNON) has a DilutionScore of 93/100, rated Critical dilution risk. Score date: August 28, 2026.

Stored shelf registration capacity: $100.0M.
Stored outstanding warrants: 250,000.
Recent SEC activity tracked for TNON: EFFECT on 2026-08-18; S-3/A on 2026-08-17; SC 13G on 2026-08-14.
Score coverage note: Float Risk is excluded because public-float data is unavailable.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,024+ tracked stocks →

📖 Dilution Education

→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

Float Risk is excluded because public-float data is unavailable.

More Research for TNON

TNON FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.

TNON — Tenon Medical, Inc. Dilution Risk Tracker